OSTX (OS Therapies) Common Stock: $0.04 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTX OS Therapies Inc OSTX
10 GF Score
Price $1.52
! 4 Warning Signs
View Full Analysis

What is OS Therapies Common Stock?

OS Therapies OSTX +0.12% 10 Common Stock is $0.04 Mil as of Mar. 2026. GuruFocus rates OSTX with a GF Score™ of 10/100. The stock has 4 warning signs investors should review.

OS Therapies's quarterly common stock increased from Sep. 2025 ($0.03 Mil) to Dec. 2025 ($0.04 Mil) and increased from Dec. 2025 ($0.04 Mil) to Mar. 2026 ($0.04 Mil).

OS Therapies's annual common stock increased from Dec. 2023 ($0.01 Mil) to Dec. 2024 ($0.02 Mil) and increased from Dec. 2024 ($0.02 Mil) to Dec. 2025 ($0.04 Mil).

OS Therapies Common Stock Historical Data

* Premium members only.

The historical data trend for OS Therapies's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OS Therapies Common Stock Chart

OS Therapies Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
0.01 0.01 0.01 0.02 0.04

OS Therapies Quarterly Data
Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.03 0.03 0.04 0.04
OSTX
10GF Score
OS Therapies Inc OSTX
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OS Therapies Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.04 Mil mean?
OS Therapies (OSTX) has a Common Stock of $0.04 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on OS Therapies and its competitors.
Is OS Therapies' Common Stock too high?
OS Therapies' current Common Stock is $0.04 Mil. Overall, OS Therapies has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does OS Therapies' Common Stock compare to RNTX and BSEM?
OS Therapies' Common Stock of $0.04 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on OS Therapies and its competitors. OS Therapies's current Common Stock is $0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OS Therapies stock overvalued right now?
OS Therapies (OSTX) has a current Common Stock of $0.04 Mil. The current Common Stock is $0.04 Mil. OS Therapies' overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For OS Therapies (OSTX), the current Common Stock is $0.04 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OS Therapies Business Description

Address 115 Pullman Crossing Road, Suite 103, Grasonville, MD, USA, 21638
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The company's mission is to address the need for new treatments in cancers of the bone in children and young adults. The company has pipeline of product candidates targeting multiple indications for solid cancers including two drug technologies: (i) OST-HER2, an off-the-shelf immunotherapy, which is a type of cancer treatment that helps the immune system fight cancer and OST-tADC which is a tunable drug conjugate (tADC) platform currently in preclinical development. Each tADC contains four main components: ligand, payload cassette adaptor, linker and payload.
10GF Score

Get the complete analysis for OSTX

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.52
Price